Nafija Serdarevic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nafija Serdarevic has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Adina Elena Stanciu
Carcinogenesis and Molecular Biology Department, Institute of Oncology “Prof. Dr. Alexandru Trestioreanu”, 022328 Bucharest, Romania
3 shared publications - Pradeep Kumar Dabla
Department of Biochemistry, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research, Associated Maulana Azad Medical College, Jawaharlal, Nehru Marg, New Delhi
2 shared publications - Adina Zamfir-Chiru-Anton
ENT Department, Grigore Alexandrescu Clinical Emergency Hospital, Carol Davila University of Medicine and Pharmacy, 011743 Bucharest, Romania
1 shared publication - Aida Hamzić-Mehmedbašić
Clinic of Nephrology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
1 shared publication - Akif Mlaco
Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina
1 shared publication - Alden Begić
Klinički centar Univerziteta Sarajevo, Bolnička 25, 71000 Sara-jevo, Bosnia and Herzegovina
1 shared publication
Latest Publications
- Open Access
- 24 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (1) , 37
The Interplay Between High Cumulative Doses of Radioactive Iodine and Type 2 Diabetes Mellitus: A Complex Cardiovascular Challenge
Starting from the metabolic profile of type 2 diabetes mellitus (T2DM), we hypothesized that the mechanisms of ¹³¹I-induced cardiotoxicity differ between patients diagnosed with differentiated thyroid cancer (DTC) with/without T2DM, with metformin potentially acting as a cardioprotective agent by mitigating inflammation in patients with T2DM. To address this hypothesis, we quantified, using ELISA, the serum concentration of several key biomarkers that reflect cardiac injury (NT-proBNP, NT-proANP, ST2/IL-33R, and cTn I) in 74 female patients with DTC/−T2DM and 25 with DTC/+T2DM treated with metformin. All patients received a cumulative oral dose of 131I exceeding 150 mCi (5.55 GBq) over approximately 53 months. Our results showed the following: (i) In DTC/−T2DM patients, high-cumulative 131I doses promote a pro-inflammatory state that accelerates the development of cardiotoxicity. Monitoring NT-proBNP, ST2/IL-33R, and cTn I in these patients may help identify those at risk of developing cardiac complications. (ii) In patients with DTC/+T2DM, high-cumulative 131I doses lead to the release of NT-proANP (r = 0.63), which signals that the atria are under significant stress. (iii) In patients with DTC/+T2DM, metformin suppresses inflammation, leading to a dose-dependent reduction in cTn I (r = −0.59). Monitoring cTn I and NT-proANP, and considering the use of metformin as part of the therapeutic strategy, could help manage cardiotoxicity in T2DM patients undergoing 131I therapy.
- 24 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (1) , 37
Open AccessThe Interplay Between High Cumulative Doses of Radioactive Iodine and Type 2 Diabetes Mellitus: A Complex Cardiovascular Challenge
Starting from the metabolic profile of type 2 diabetes mellitus (T2DM), we hypothesized that the mechanisms of ¹³¹I-induced cardiotoxicity differ between patients diagnosed with differentiated thyroid cancer (DTC) with/without T2DM, with metformin potentially acting as a cardioprotective agent by mitigating inflammation in patients with T2DM. To address this hypothesis, we quantified, using ELISA, the serum concentration of several key biomarkers that reflect cardiac injury (NT-proBNP, NT-proANP, ST2/IL-33R, and cTn I) in 74 female patients with DTC/−T2DM and 25 with DTC/+T2DM treated with metformin. All patients received a cumulative oral dose of 131I exceeding 150 mCi (5.55 GBq) over approximately 53 months. Our results showed the following: (i) In DTC/−T2DM patients, high-cumulative 131I doses promote a pro-inflammatory state that accelerates the development of cardiotoxicity. Monitoring NT-proBNP, ST2/IL-33R, and cTn I in these patients may help identify those at risk of developing cardiac complications. (ii) In patients with DTC/+T2DM, high-cumulative 131I doses lead to the release of NT-proANP (r = 0.63), which signals that the atria are under significant stress. (iii) In patients with DTC/+T2DM, metformin suppresses inflammation, leading to a dose-dependent reduction in cTn I (r = −0.59). Monitoring cTn I and NT-proANP, and considering the use of metformin as part of the therapeutic strategy, could help manage cardiotoxicity in T2DM patients undergoing 131I therapy.
- 1 December 2023
- Published by University of Sarajevo Faculty of Health Sciences in Kongres "Dani zdravstvenih nauka"-Zbornik sažetaka
INTERFERENCIJA SA BIOTINOM U IMUNOHEMIJSKIM TESTOVIMA
Nafija Serdarević* Institut za kliničku biohemiju sa imunologijom, Klinički centar Univerziteta u Sarajevu; Univerzitet u Sarajevu-Fakultet zdravstvenih studija *Dopisni autor: Nafija Serdarević, Institut za kliničku biohemiju sa imunologijom, Klinički centar Univerziteta u Sarajevu, Univerzitet u Sarajevu-Fakultet zdravstvenih studija, Sarajevo, Bosna i Hercegovina, email:nafija.serdarevic@fzs.unsa.ba DOI: Sažetak Uvod: Biotin, vitamin H ili vitamin B7, je topiv u vodi i neophodan je
- 1 December 2023
- Published by University of Sarajevo Faculty of Health Sciences in Kongres "Dani zdravstvenih nauka"-Zbornik sažetaka
INTERFERENCIJA SA BIOTINOM U IMUNOHEMIJSKIM TESTOVIMA
Nafija Serdarević* Institut za kliničku biohemiju sa imunologijom, Klinički centar Univerziteta u Sarajevu; Univerzitet u Sarajevu-Fakultet zdravstvenih studija *Dopisni autor: Nafija Serdarević, Institut za kliničku biohemiju sa imunologijom, Klinički centar Univerziteta u Sarajevu, Univerzitet u Sarajevu-Fakultet zdravstvenih studija, Sarajevo, Bosna i Hercegovina, email:nafija.serdarevic@fzs.unsa.ba DOI: Sažetak Uvod: Biotin, vitamin H ili vitamin B7, je topiv u vodi i neophodan je
- 1 December 2023
- Published by University of Sarajevo Faculty of Health Sciences in Kongres "Dani zdravstvenih nauka"-Zbornik sažetaka
OCCUPATIONAL HAZARDS AND RISK ASSESSMENT IN BIOMEDICAL LABORATORIES
Sabina Šegalo1, Arzija Pašalić1, Amra Mačak Hadžiomerović1, Nafija Serdarević 1,2 1University of Sarajevo, Faculty of Health Studies, 2 Clinical Center Univeristy of Sarajevo, Sarajevo, Bosnia and Herzegovina Corresponding author: Sabina Šegalo, University of Sarajevo, Faculty of Health Studies, Sarajevo, Bosnia and Herzegovina,email:sabina.segalo@fzs.unsa.ba DOI: Abstract Introduction: Laboratory professionals (LP) are exposed to various hazards in the workplace, whose direct and/or cumulative
- 1 December 2023
- Published by University of Sarajevo Faculty of Health Sciences in Kongres "Dani zdravstvenih nauka"-Zbornik sažetaka
OCCUPATIONAL HAZARDS AND RISK ASSESSMENT IN BIOMEDICAL LABORATORIES
Sabina Šegalo1, Arzija Pašalić1, Amra Mačak Hadžiomerović1, Nafija Serdarević 1,2 1University of Sarajevo, Faculty of Health Studies, 2 Clinical Center Univeristy of Sarajevo, Sarajevo, Bosnia and Herzegovina Corresponding author: Sabina Šegalo, University of Sarajevo, Faculty of Health Studies, Sarajevo, Bosnia and Herzegovina,email:sabina.segalo@fzs.unsa.ba DOI: Abstract Introduction: Laboratory professionals (LP) are exposed to various hazards in the workplace, whose direct and/or cumulative
- Open Access
- 1 December 2022
- Published by Walter de Gruyter GmbH in Journal of Interdisciplinary Medicine
- Vol. 7 (4) , 81-87
Assessment of C-Reactive Protein, Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients at Different Stages of Chronic Kidney Disease
Sciendo provides publishing services and solutions to academic and professional organizations and individual authors. We publish journals, books, conference proceedings and a variety of other publications.
- 1 December 2022
- Published by Walter de Gruyter GmbH in Journal of Interdisciplinary Medicine
- Vol. 7 (4) , 81-87
Open AccessAssessment of C-Reactive Protein, Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients at Different Stages of Chronic Kidney Disease
Sciendo provides publishing services and solutions to academic and professional organizations and individual authors. We publish journals, books, conference proceedings and a variety of other publications.
- 1 October 2019
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 14 (9-10) , 221
Survival of heart failure patients with reduced and preserved ejection fraction is not different!
- 1 October 2019
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 14 (9-10) , 221
Survival of heart failure patients with reduced and preserved ejection fraction is not different!
- Open Access
- 13 February 2019
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 36 (2) , 151-158
Systematic Differences Between Total and Free Prostate-Specific Antigen Immunoassays: Comparison Using Passing and Bablok Regression
Recent studies have shown that there are systematic differences among total and free prostate-specificantigen (PSA) immunoassays. In this study we analyzedintermethod differences in total PSA (tPSA) and free PSA(fPSA) measurement using ARCHITECT i2000SR (Abbott Diagnostics) and COBAS E601 (Roche Diagnostics). A number of 160 blood samples were tested for tPSA and 50 samples for fPSA (selecting only sampleswith tPSA: 4.1–10.0 μg/L). Passing–Bablok regression analysis was used to compare the two analytical methods fortPSA, fPSA and percentage of fPSA (%fPSA). A strong correlation was noticed between ARCHITECT i2000SR and COBAS E601 for tPSA, fPSA and %fPSA (r between 0.94 and 0.99). Concentrations of tPSA and fPSA measured by COBAS E601 were higher thanthose measured by ARCHITECT i2000SR with a bias of 0.8 μg/L for tPSA and 0.14 μg/L for fPSA. Analyzing therelative difference between methods for fPSA and %fPSA, COBAS E601 exceed a 10% relative difference limit. Our study confirms that there are differences in measured concentrations of tPSA and fPSA byvarious commercial methods. Because clinical judgment on subsequent diagnostic procedures, such as prostatebiopsy, is based on tPSA and fPSA results, tests harmonization should be a priority.
- 13 February 2019
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 36 (2) , 151-158
Open AccessSystematic Differences Between Total and Free Prostate-Specific Antigen Immunoassays: Comparison Using Passing and Bablok Regression
Recent studies have shown that there are systematic differences among total and free prostate-specificantigen (PSA) immunoassays. In this study we analyzedintermethod differences in total PSA (tPSA) and free PSA(fPSA) measurement using ARCHITECT i2000SR (Abbott Diagnostics) and COBAS E601 (Roche Diagnostics). A number of 160 blood samples were tested for tPSA and 50 samples for fPSA (selecting only sampleswith tPSA: 4.1–10.0 μg/L). Passing–Bablok regression analysis was used to compare the two analytical methods fortPSA, fPSA and percentage of fPSA (%fPSA). A strong correlation was noticed between ARCHITECT i2000SR and COBAS E601 for tPSA, fPSA and %fPSA (r between 0.94 and 0.99). Concentrations of tPSA and fPSA measured by COBAS E601 were higher thanthose measured by ARCHITECT i2000SR with a bias of 0.8 μg/L for tPSA and 0.14 μg/L for fPSA. Analyzing therelative difference between methods for fPSA and %fPSA, COBAS E601 exceed a 10% relative difference limit. Our study confirms that there are differences in measured concentrations of tPSA and fPSA byvarious commercial methods. Because clinical judgment on subsequent diagnostic procedures, such as prostatebiopsy, is based on tPSA and fPSA results, tests harmonization should be a priority.
- Open Access
- 1 January 2019
- Published by ScopeMed in Medical Archives
- Vol. 73 (2) , 104-108
The Cigarette Smoking, Coffee and Supplements Intake at Students of Sarajevo University
The dietary supplements are defined as vitamins and minerals or herbal products and are typically given in the form of a capsule or tablet. The nonsmokers are more attempted to use dietary supplements than individuals who smoke. In our investigation, we examined associations between vitamin B, folic acid, multivitamin or mineral intake among the student population and their correlation with smoking prevalence and drinking coffee. We used a questionnaire to examine the general characteristics of the subjects, age, sex, their lifestyle, cigarette smoking, coffee intake and their use of dietary supplements. Data were collected from participants of the University of Sarajevo and a longitudinal study of 960 men and women aged 18-24 years from 2017 to 2018 was conducted. The results showed that 32% of students took vitamin B supplements and 10% folic acid. In opposite, more than half of students took multivitamins (59.5%) and minerals (60.4%) less than one year. About a quarter or less took multivitamins (23.9%) and minerals (24.3%) for years. Less than 20% of students took multivitamins and minerals within a period of one year. In student population smoking prevalence was estimated at 21.2% and coffee intake in 71.2%. The smoking and use of vitamin B supplements were independent of each other, p = 0.201. The use of folic acid did not depend on smoking p = 0.501. There were no observed correlations between multivitamin and mineral supplement consumption compared to smoking status or drinking coffee. Deficient dietary intake of folic acid and B vitamins from food and supplemental sources appear to be one of the atherosclerosis incidences. Further studies should examine associations between dietary supplements intake and lifestyle of students, as well as smoking status and coffee intake.
- 1 January 2019
- Published by ScopeMed in Medical Archives
- Vol. 73 (2) , 104-108
Open AccessThe Cigarette Smoking, Coffee and Supplements Intake at Students of Sarajevo University
The dietary supplements are defined as vitamins and minerals or herbal products and are typically given in the form of a capsule or tablet. The nonsmokers are more attempted to use dietary supplements than individuals who smoke. In our investigation, we examined associations between vitamin B, folic acid, multivitamin or mineral intake among the student population and their correlation with smoking prevalence and drinking coffee. We used a questionnaire to examine the general characteristics of the subjects, age, sex, their lifestyle, cigarette smoking, coffee intake and their use of dietary supplements. Data were collected from participants of the University of Sarajevo and a longitudinal study of 960 men and women aged 18-24 years from 2017 to 2018 was conducted. The results showed that 32% of students took vitamin B supplements and 10% folic acid. In opposite, more than half of students took multivitamins (59.5%) and minerals (60.4%) less than one year. About a quarter or less took multivitamins (23.9%) and minerals (24.3%) for years. Less than 20% of students took multivitamins and minerals within a period of one year. In student population smoking prevalence was estimated at 21.2% and coffee intake in 71.2%. The smoking and use of vitamin B supplements were independent of each other, p = 0.201. The use of folic acid did not depend on smoking p = 0.501. There were no observed correlations between multivitamin and mineral supplement consumption compared to smoking status or drinking coffee. Deficient dietary intake of folic acid and B vitamins from food and supplemental sources appear to be one of the atherosclerosis incidences. Further studies should examine associations between dietary supplements intake and lifestyle of students, as well as smoking status and coffee intake.
- Open Access
- 1 January 2019
- Published by ScopeMed in Materia Socio Medica
- Vol. 31 (1) , 53-56
The Vitamine Source, Usual Food Intake at Students
Inadequate vitamin B 12, folate status and B6 are associated with an increased risk for chronic diseases that may have a negative impact on the health. The aim of our study was to investigate dietary intake of vitamin B12, B6 and folates from various foods among the university students. Dietary intake of foods having vitamins B12, B6 and folate was assessed among the students of University of Sarajevo, 19-22 years old, from 2017 to 2018. The participants were interviewed to collect information regarding age, socioeconomic status, B12, folate, B6 vitamin, and usual food intake during one week. The main sources of vitamin B12 and B6 in the students' diet were chicken white meat (51.8-53.7 %), beef (45-63 %), cream (62.2 -72.1 %), sardines in oil (47.9-52.2 %), tuna (55.2 -60.4 %), cheese edamer (80.1%) and cheese feta (67.4%-73%). The foods with a high source of vitamin B12 and B6 but rarely consumed were fish, shellfish, salmon, roasted trout and mackerel. Sufficient folate intake was mainly achieved through dietary intake of beans (48.5-57.2%) and oatmeal (46.3-48.2%), while folate-insufficient diet resulted from intake of spinach (30.9-35 %), turkey (26.2-33.4 %), lentils (16.9-19.7 %) and soy (9.4-15.5%). Our results show that there is an important percentage of the students in Canton Sarajevo that do not meet the recommended intakes for vitamin B12 and B6 and folate. Additional research is needed to establish the best cost-effective public health approach to achieve sufficient intake of these vitamins.
- 1 January 2019
- Published by ScopeMed in Materia Socio Medica
- Vol. 31 (1) , 53-56
Open AccessThe Vitamine Source, Usual Food Intake at Students
Inadequate vitamin B 12, folate status and B6 are associated with an increased risk for chronic diseases that may have a negative impact on the health. The aim of our study was to investigate dietary intake of vitamin B12, B6 and folates from various foods among the university students. Dietary intake of foods having vitamins B12, B6 and folate was assessed among the students of University of Sarajevo, 19-22 years old, from 2017 to 2018. The participants were interviewed to collect information regarding age, socioeconomic status, B12, folate, B6 vitamin, and usual food intake during one week. The main sources of vitamin B12 and B6 in the students' diet were chicken white meat (51.8-53.7 %), beef (45-63 %), cream (62.2 -72.1 %), sardines in oil (47.9-52.2 %), tuna (55.2 -60.4 %), cheese edamer (80.1%) and cheese feta (67.4%-73%). The foods with a high source of vitamin B12 and B6 but rarely consumed were fish, shellfish, salmon, roasted trout and mackerel. Sufficient folate intake was mainly achieved through dietary intake of beans (48.5-57.2%) and oatmeal (46.3-48.2%), while folate-insufficient diet resulted from intake of spinach (30.9-35 %), turkey (26.2-33.4 %), lentils (16.9-19.7 %) and soy (9.4-15.5%). Our results show that there is an important percentage of the students in Canton Sarajevo that do not meet the recommended intakes for vitamin B12 and B6 and folate. Additional research is needed to establish the best cost-effective public health approach to achieve sufficient intake of these vitamins.
- Open Access
- 1 January 2018
- Published by ScopeMed in Acta Informatica Medica
- Vol. 26 (4) , 235-239
The Comparison Between Different Immunoassays for Serum Carbohydrate Antigen (CA 19-9) Concentration Measurement
The carbohydrate antigen (CA 19-9) is a marker for pancreatic and colorectal carcinoma. In our study, we have investigated the level of CA 19-9 at 50 patients with benign and malign disease using three immunoassays. The COBAS e 601 (Roche) uses an ECLIA, Architect i2000 analyzer (Abbott) uses CMIA and VITROS 5600 uses integrated System Intellicheck Technology with cut off 0.0-37.0 U/mL for determination of CA 19-9. Results were with a statistical significance of p < 0.05. Comparison of CA19-9 on COBAS with Architect show correlation coefficient R = 0.708. The results showed a regression line between immunoassay in patients with CA 19-9 treatment of y (Cobas) = 16.14 x (Architect) + 0.53. The comparison of CA19-9 on Architect and Cobas show correlation coefficient R = 0.709. The results showed regression line between immunoassay in patients with CA 19-9 treatment of y (Vitros) =-5.558 + 2.432 x (Architect) and correlation coefficient R = 0. 990. The mean concentration of CA 19-9 in the CMIA method was 41.49 U/mL, Intellicheck Technology was 103.45 U/mL and using ECLIA method was 47.25 U/mL at patients. Patients should be monitored on a single method to avoid differences in the results. The various immunoassay techniques for the detection of CA 19-9 tumor marker using different monoclonal antibodies, which leads to different results. Different antibodies recognize different parts of the molecule, and antigen heterogeneity may account in part for inter-method differences.
- 1 January 2018
- Published by ScopeMed in Acta Informatica Medica
- Vol. 26 (4) , 235-239
Open AccessThe Comparison Between Different Immunoassays for Serum Carbohydrate Antigen (CA 19-9) Concentration Measurement
The carbohydrate antigen (CA 19-9) is a marker for pancreatic and colorectal carcinoma. In our study, we have investigated the level of CA 19-9 at 50 patients with benign and malign disease using three immunoassays. The COBAS e 601 (Roche) uses an ECLIA, Architect i2000 analyzer (Abbott) uses CMIA and VITROS 5600 uses integrated System Intellicheck Technology with cut off 0.0-37.0 U/mL for determination of CA 19-9. Results were with a statistical significance of p < 0.05. Comparison of CA19-9 on COBAS with Architect show correlation coefficient R = 0.708. The results showed a regression line between immunoassay in patients with CA 19-9 treatment of y (Cobas) = 16.14 x (Architect) + 0.53. The comparison of CA19-9 on Architect and Cobas show correlation coefficient R = 0.709. The results showed regression line between immunoassay in patients with CA 19-9 treatment of y (Vitros) =-5.558 + 2.432 x (Architect) and correlation coefficient R = 0. 990. The mean concentration of CA 19-9 in the CMIA method was 41.49 U/mL, Intellicheck Technology was 103.45 U/mL and using ECLIA method was 47.25 U/mL at patients. Patients should be monitored on a single method to avoid differences in the results. The various immunoassay techniques for the detection of CA 19-9 tumor marker using different monoclonal antibodies, which leads to different results. Different antibodies recognize different parts of the molecule, and antigen heterogeneity may account in part for inter-method differences.
- 1 January 2013
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 59 (09+10/2013) , 1129-33
Comparison of Architect I 2000 for Determination of Scc with IMX Determination of SCC with Different Methods
SCC (squamous cell carcinoma) antigen (SSCA), a tumor marker, is already used for the diagnosis and follow-up of carcinoma of the cervix and lungs. The aim of our study was the determination of SCCA concentration in 96 serum samples using CMIA (chemiluminesecent microparticle immnoassay) on an Architect i2000 (Abbott Diagnostics) and MEIA (microparticle enzyme immnoassay) on an IMx Chemistry Analyzer (Abbott Diagnostics). In our investigation we used a CMIA (chemiluminesecent microparticle immnoassay) Architect i2000 and MEIA (microparticle enzyme immnoassay) Imx Chemistry Analyzer for SCCA determination. All patients were hospitalized at the Department of Gynecologic Oncology and Department for Oncology at the University Clinics Center of Sarajevo. The normal serum range of SCCA should be < 0.1 microg/L. The quality control, precision and accuracy of the Architect i2000 were assessed. The quality control was done using quality control serums for low (X = 2.17 microg/L), medium (X = 10.23 microg/L), and high (X = 48.99 microg/L) range. The precision for the Architect i2000 has a CV of 3.44% to 4.44%. We established that the main difference between Architect i2000 and IMx was statistically significant at p < 0.05 according to Student's t-test. The correlation coefficient was r = 0.990. The some samples have higher concentrations on the Architect than on the IMx because the sensitivity of the Architect assay is high (< 0.1 microg/L). The CMIA Architect technology is an applicable method significant in diagnostic of SCCA.
- 1 January 2013
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 59 (09+10/2013) , 1129-33
Comparison of Architect I 2000 for Determination of Scc with IMX Determination of SCC with Different Methods
SCC (squamous cell carcinoma) antigen (SSCA), a tumor marker, is already used for the diagnosis and follow-up of carcinoma of the cervix and lungs. The aim of our study was the determination of SCCA concentration in 96 serum samples using CMIA (chemiluminesecent microparticle immnoassay) on an Architect i2000 (Abbott Diagnostics) and MEIA (microparticle enzyme immnoassay) on an IMx Chemistry Analyzer (Abbott Diagnostics). In our investigation we used a CMIA (chemiluminesecent microparticle immnoassay) Architect i2000 and MEIA (microparticle enzyme immnoassay) Imx Chemistry Analyzer for SCCA determination. All patients were hospitalized at the Department of Gynecologic Oncology and Department for Oncology at the University Clinics Center of Sarajevo. The normal serum range of SCCA should be < 0.1 microg/L. The quality control, precision and accuracy of the Architect i2000 were assessed. The quality control was done using quality control serums for low (X = 2.17 microg/L), medium (X = 10.23 microg/L), and high (X = 48.99 microg/L) range. The precision for the Architect i2000 has a CV of 3.44% to 4.44%. We established that the main difference between Architect i2000 and IMx was statistically significant at p < 0.05 according to Student's t-test. The correlation coefficient was r = 0.990. The some samples have higher concentrations on the Architect than on the IMx because the sensitivity of the Architect assay is high (< 0.1 microg/L). The CMIA Architect technology is an applicable method significant in diagnostic of SCCA.